National Institute of Mental Health; Amended Notice of Meeting
---
identifier: "/us/fr/2020-12258"
source: "fr"
legal_status: "authoritative_unofficial"
title: "National Institute of Mental Health; Amended Notice of Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "2020-12258"
section_name: "National Institute of Mental Health; Amended Notice of Meeting"
positive_law: false
currency: "2020-06-08"
last_updated: "2020-06-08"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2020-12258"
document_type: "notice"
publication_date: "2020-06-08"
agencies:
- "Health and Human Services Department"
- "National Institutes of Health"
fr_citation: "85 FR 35104"
fr_volume: 85
---
# National Institute of Mental Health; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the National Institute of Mental Health Special Emphasis Panel, June 30, 2020, 11:00 a.m. to June 30, 2020, 4:00 p.m., National Institutes of Health, Neuroscience Center, 6001 Executive Blvd., Rockville, MD 20852 which was published in the *Federal Register* on June 2, 2020, 85 FR 33694.
This notice is to amend the title of the meeting from “Early Phase Clinical Trials—Pharmacological and Device-based Interventions,” to “Early Phase Clinical Trials for Psychosocial Interventions.” The meeting is closed to the public.
Dated: June 2, 2020.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.